<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Since the introduction of recombinant tissue plasminogen activator and thrombolysis, <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> has become a treatable disorder if the patient presents within the 4.5-hour time window </plain></SENT>
<SENT sid="1" pm="."><plain>Typically, <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> is caused by atherosclerotic disease involving large or small cerebral arteries or secondary to a cardioembolic source often associated with <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In the over-65-year age group, more rare causes of <z:hpo ids='HP_0001297'>stroke</z:hpo>, such as <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndromes</z:e>, are unusual; such <z:hpo ids='HP_0001297'>stroke</z:hpo> etiologies are mostly seen in a younger age group (&lt;55 years) </plain></SENT>
<SENT sid="3" pm="."><plain>Here we describe <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> in three patients &gt;65 years with <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C-associated <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>We suggest that screening for antiphospholipid disorders in the older patient might be warranted, with potential implications for therapeutic management and secondary <z:hpo ids='HP_0001297'>stroke</z:hpo> prevention </plain></SENT>
</text></document>